A systematic review and meta-analysis of eight studies found elevated serum TK1 in prostate cancer and an association with ...
Darolutamide with ADT significantly prolongs rPFS in metastatic prostate cancer while preserving tolerability. Read more here ...
A new deep learning architecture called TexTNet integrates local binary pattern texture features into a Swin Transformer's ...
New late-breaking data to be presented today by the Australian and New Zealand Urogenital and Prostate (ANZUP) Clinical ...
An Oxford study of more than 6,000 blood proteins linked 12 to prostate cancer diagnosed over 15 years later, and seven to ...
Salvage radiation after surgery: If PSA rises after surgery, radiation to the area where the prostate was can still be ...
ORION CORPORATION PRESS RELEASE 24 OCTOBER 2026 at 9.35 EEST Darolutamide plus ADT and radiation therapy reduces risk of ...
A prostate cancer diagnosis can leave men weighing several consequential decisions, from active surveillance and regular monitoring to surgery and radiation therapy.
Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to radiation and active surveillance. Because prostate cancer grows slowly, patients ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today pivotal results from the Phase III ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use ...
Early-stage studies presented at ESMO reported promising activity for several experimental treatments for advanced prostate cancer. Johnson & Johnson’s oral JNJ-6143 produced substantial PSA declines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results